Clear Aligners vs Fixed Appliances for Molar Distalization Using Infrazygomatic Crest Screws
15. juli 2026 oppdatert av: Ahmet Yağcı, TC Erciyes University
Evaluation of the Treatment Effects of Different Clear Aligner and Fixed Appliance Systems in Maxillary Posterior Distalization Using Infrazygomatic Crest Screws: An In-Vivo Randomized Clinical Study
This study compares three different methods of moving upper back teeth backward (distalization) to create space for crowded or protruding teeth, all supported by small temporary screws placed in the cheekbone area (infrazygomatic crest screws).
Participants were randomly assigned to one of three treatment types: traditional fixed braces (Pitts21 system), Invisalign clear aligners, or ClearCorrect clear aligners.
The study measures how effectively each method moves the back teeth, how long treatment takes, and how comfortable and practical each method is for patients.
The goal is to help orthodontists and patients choose the most effective and efficient treatment option for this type of tooth movement.
Studieoversikt
Status
Fullført
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
This prospective randomized clinical trial included 35 subjects aged 13-18 years with skeletal Class I, dental Class II malocclusion, randomly allocated to Pitts21 fixed appliance (n=12), Invisalign (n=12), or ClearCorrect (n=11) treatment groups.
Unilateral or bilateral infrazygomatic crest (IZC) miniscrews were placed in all subjects, and distalization forces were applied via intraoral elastics.
Lateral cephalometric radiographs and digital dental models (acquired with a 3Shape TRIOS 3 intraoral scanner) were obtained at the start (T0) and end (T1) of distalization to assess skeletal, dental, and soft tissue changes.
Patient-reported outcomes were also collected, including pain (Visual Analog Scale) and anxiety (Çapa Anxiety Scale).
Data were analyzed using IBM SPSS v23 and R 4.4.1;
normality was assessed with the Shapiro-Wilk test.
Between-group comparisons used one-way ANOVA or the Kruskal-Wallis H test, and within-group comparisons over time used paired t-test, Wilcoxon, repeated measures ANOVA, or Friedman test.
Group×time and group×tooth interactions were evaluated using Generalized Estimating Equations and Robust Mixed ANOVA, with Bonferroni, Games-Howell, or Holm corrections applied for multiple comparisons.
Studietype
Intervensjonell
Registrering (Faktiske)
37
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
-
Kayseri, Tyrkia (Türkiye), 38000
- Erciyes University, Faculty of Dentistry, Department of Orthodontics
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Barn
- Voksen
Tar imot friske frivillige
Nei
Beskrivelse
Inclusion Criteria:
- Skeletal Class I (ANB angle 0-4°), dental Class II malocclusion treatable with molar distalization
- Need for unilateral or bilateral distalization of the first molars in the range of 2-4.5 mm
- Chronological age between 13 and 18 years, regardless of skeletal age
- Normal or hypodivergent growth pattern (SN-GoGn < 39°)
- Mild to moderate maxillary crowding (less than 6 mm) and minimal or no mandibular crowding (less than 3 mm)
- No previously extracted maxillary teeth, excluding third molars
- Erupted permanent second molars
- Good oral hygiene
- Healthy periodontal tissues
Exclusion Criteria:
- Need for orthodontic tooth extraction or functional appliance therapy
- Presence of systemic disease
- Congenital or acquired craniofacial deformity involving the condyle or mandible
- Poor patient cooperation
- History of allergy to any metal
- Pre-existing root resorption prior to treatment
- Previous orthodontic treatment
- Abnormal position, depth of impaction, or close proximity to adjacent anatomical structures (sinus, neurovascular structures) of the maxillary third molar that would make its surgical extraction risky
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Aktiv komparator: Group A ( Pitts21® Fixed Appliance )
Participants received maxillary posterior distalization using the Pitts21® fixed orthodontic appliance system, anchored with infrazygomatic crest (IZC) miniscrews and intraoral elastics for distalization force.
|
Fixed orthodontic brackets (Pitts21 system) used for maxillary posterior distalization, anchored with infrazygomatic crest miniscrews and intraoral elastics.
Andre navn:
|
|
Eksperimentell: Group B ( Invisalign® clear aligners)
Participants received maxillary posterior distalization using Invisalign® clear aligners, anchored with infrazygomatic crest (IZC) miniscrews and intraoral elastics for distalization force.
|
Clear aligner system (Invisalign) used for maxillary posterior distalization, anchored with infrazygomatic crest miniscrews and intraoral elastics.
Andre navn:
|
|
Eksperimentell: Group C ( ClearCorrect® clear aligners)
Participants received maxillary posterior distalization using ClearCorrect® clear aligners, anchored with infrazygomatic crest (IZC) miniscrews and intraoral elastics for distalization force.
|
Clear aligner system (ClearCorrect) used for maxillary posterior distalization, anchored with infrazygomatic crest miniscrews and intraoral elastics.
Andre navn:
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Amount of Maxillary Posterior Tooth Distalization
Tidsramme: From the date of infrazygomatic crest miniscrew placement and initiation of distalization force (T0) until the end of the active distalization phase (T1), assessed up to 13 months
|
The amount of distalization of the maxillary premolars and molars (U4, U5, U6, U7) was measured in millimeters using three-dimensional digital dental model analysis, comparing pre-treatment (T0) and post-distalization (T1) records.
|
From the date of infrazygomatic crest miniscrew placement and initiation of distalization force (T0) until the end of the active distalization phase (T1), assessed up to 13 months
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Total Distalization Duration
Tidsramme: From the date of miniscrew placement and start of distalization force (T0) until the date of completion of active distalization (T1), assessed up to 13 months
|
The total duration of the distalization phase, calculated as the time interval between the start of force application (T0) and the completion of active distalization (T1).
|
From the date of miniscrew placement and start of distalization force (T0) until the date of completion of active distalization (T1), assessed up to 13 months
|
Andre resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Distalization Efficacy in Clear Aligner Groups
Tidsramme: From treatment planning (T0) until the end of active distalization (T1), assessed up to 13 months
|
Distalization efficacy was calculated as the ratio of achieved to planned tooth movement (Efficacy = Achieved/Planned × 100), based on digital treatment planning, for the Invisalign and ClearCorrect groups.
|
From treatment planning (T0) until the end of active distalization (T1), assessed up to 13 months
|
|
Infrazygomatic Crest Miniscrew Success Rate
Tidsramme: From the date of miniscrew placement until the end of active distalization, assessed up to 13 months
|
The success rate of infrazygomatic crest miniscrews used for anchorage was recorded, defined as the proportion of miniscrews remaining stable and functional throughout the distalization period without requiring replacement.
|
From the date of miniscrew placement until the end of active distalization, assessed up to 13 months
|
|
Cephalometric Skeletal, Dental, and Soft Tissue Changes
Tidsramme: From the date of miniscrew placement and start of distalization force (T0) until the end of active distalization (T1), assessed up to 13 months
|
Skeletal, dental, and soft tissue changes were assessed using lateral cephalometric radiographs, comparing measurements obtained at the beginning (T0) and end (T1) of distalization.
|
From the date of miniscrew placement and start of distalization force (T0) until the end of active distalization (T1), assessed up to 13 months
|
|
Rotation of Premolars and Molars During Distalization
Tidsramme: From T0 to T1, assessed up to 13 months
|
Changes in the rotational position of the maxillary premolars and molars (U4-U7) were measured using digital dental models, comparing T0 and T1 records.
|
From T0 to T1, assessed up to 13 months
|
|
Mesiodistal Tipping of Premolars and Molars During Distalization
Tidsramme: From T0 to T1, assessed up to 13 months
|
Changes in mesiodistal crown angulation (tipping) of the maxillary premolars and molars (U4-U7) were measured using digital dental models, comparing T0 and T1 records.
|
From T0 to T1, assessed up to 13 months
|
|
Transverse Width Changes in the Maxillary Posterior Region
Tidsramme: From T0 to T1, assessed up to 13 months
|
Changes in transverse arch width at the level of the premolars and molars (U4-U7) were measured using digital dental models, comparing T0 and T1 records.
|
From T0 to T1, assessed up to 13 months
|
|
Pain Level Assessed by Visual Analog Scale
Tidsramme: From day 1 after miniscrew placement/appliance activation up to the end of active distalization, assessed at 5 time points (day 1, week 1, month 1, month 3, and end of distalization; up to 13 months)
|
Pain associated with treatment was assessed using the Visual Analog Scale (VAS, 0-10) at multiple time points: day 1, week 1, month 1, month 3, and end of distalization.
|
From day 1 after miniscrew placement/appliance activation up to the end of active distalization, assessed at 5 time points (day 1, week 1, month 1, month 3, and end of distalization; up to 13 months)
|
|
Anxiety Level Assessed by the Çapa Anxiety Scale
Tidsramme: From day 1 after miniscrew placement/appliance activation up to the end of active distalization, assessed at 5 time points (day 1, week 1, month 1, month 3, and end of distalization; up to 13 months)
|
Patient anxiety related to treatment was assessed using the Çapa Anxiety Scale at multiple time points: day 1, week 1, month 1, month 3, and end of distalization.
|
From day 1 after miniscrew placement/appliance activation up to the end of active distalization, assessed at 5 time points (day 1, week 1, month 1, month 3, and end of distalization; up to 13 months)
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
6. juni 2024
Primær fullføring (Faktiske)
12. januar 2026
Studiet fullført (Faktiske)
18. februar 2026
Datoer for studieregistrering
Først innsendt
15. juli 2026
Først innsendt som oppfylte QC-kriteriene
15. juli 2026
Først lagt ut (Faktiske)
20. juli 2026
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
20. juli 2026
Siste oppdatering sendt inn som oppfylte QC-kriteriene
15. juli 2026
Sist bekreftet
1. juli 2026
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Andre studie-ID-numre
- TDH-2025-15402
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
NEI
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .